000 01571 a2200385 4500
005 20250516163740.0
264 0 _c20131203
008 201312s 0 0 eng d
022 _a1872-7905
024 7 _a10.1016/j.jim.2013.07.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeloki, Lorea
245 0 0 _aThe abrogation of TCR-independent interactions with human serum ensures a selective capture of therapeutic virus-specific CD8+ T-cells by multimer technology in Adoptive Immunotherapy.
_h[electronic resource]
260 _bJournal of immunological methods
_cOct 2013
300 _a168-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCytomegalovirus
_ximmunology
650 0 4 _aHistocompatibility Antigens Class I
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aLeukocytes, Mononuclear
_ximmunology
650 0 4 _aPhosphoproteins
_ximmunology
650 0 4 _aReceptors, Antigen, T-Cell
_ximmunology
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aViral Matrix Proteins
_ximmunology
700 1 _aCiáurriz, Miriam
700 1 _aMansilla, Cristina
700 1 _aBandrés, Eva
700 1 _aRodríguez-Calvillo, Mercedes
700 1 _aRamírez, Natalia
700 1 _aOlavarría, Eduardo
773 0 _tJournal of immunological methods
_gvol. 396
_gno. 1-2
_gp. 168-72
856 4 0 _uhttps://doi.org/10.1016/j.jim.2013.07.014
_zAvailable from publisher's website
999 _c22992780
_d22992780